A study has examined the safety of the herpes zoster vaccine in the Aotearoa New Zealand population. The vaccine may have additional benefits, such as reducing the risk of stroke and heart attack, although its primary purpose is to protect against shingles. The study's findings are part of a broader discussion about vaccine effectiveness and protection, including for adults with weakened immune systems.